AGMO and Other metabolic disease: Although the variants of DGKB/TMEM195 were not studied in terms of AGMO/TMEM195 expression or function, the region is considered as metabolic “risk gene”, and the GWAS suggest that AGMO is involved in human metabolic diseases.